Macular Edema Incidence/Severity Reduction With Nevanac
Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate NEVANAC in patients with diabetic retinopathy who
developed macular edema (ME) within 90 days following cataract surgery.